Tempest Therapeutics

Parachute over La Jolla California
Biotech

Metsera sale architect swings to Structure—Chutes & Ladders

Metsera acquisition architect swings to Structure. Vir CMO exits after less than 2 years. Leal reels in Big Pharma vets to exec team.
Throwing a life preserver

Tempest strikes all-stock deal for Factor’s CAR-T pipeline, CEO

Nov 19, 2025 12:22pm
reducing people on team

Tempest lays off 80% of workforce to ride out cash crunch

Apr 21, 2025 8:20am
lighthouse in stormy night

Tempest, amid cash drought, hunts for liver cancer drug partner

Apr 10, 2025 7:24am
beacon of light lighthouse stormy

Tempest's triplet shows boost over Roche combo in liver cancer

Oct 11, 2023 11:00am